Patent details

EP1136075 Title: Combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection

Basic Information

Publication number:
EP1136075
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Revoked
Application number:
EP011136280
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection
French Title of Invention:
Thérapie combinée pour l' éradication de l' HCV-ARN détectable chez des patients atteints d' une infection d' hépatite C chronique
German Title of Invention:
Kombinationstherapie zur Entfernung von nachweisbarer HCV-RNS in Patienten mit chronischer Hepatitis C-Infection
SPC Number:

Dates

Filing date:
07/08/1998
Grant date:
15/01/2003
EP Publication Date:
15/01/2003
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
26/09/2001
EP B1 Publication Date:
15/01/2003
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
07/08/2018
Renunciation date:
Revocation date:
03/05/2007
Annulment date:

Owner

From:
07/08/1998
 
 

Name:
SCHERING CORPORATION
Address:
2000 Galloping Hill Road, Kenilworth New Jersey 07033, United States (US)

Agent

Name:
WAXWEILER Jean
From:
31/01/2003
Address:
PO Box 1502, 1015, Luxembourg, Luxembourg (LU)
To:

Inventor

Name:
Albrecht Janice K.
Address:
United States (US)

Priority

1

Priority Number:
938033
Priority Date:
21/09/1997
Priority Country:
United States (US)

2

Priority Number:
935123
Priority Date:
22/09/1997
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 38/21;
Filing date Document type Number of pages